-
I133453-250mg(R)-Boc-4-fluoro-β-Phe-OH.
-
R465176-500mg(R)-Boc-4-methoxy-β-Phe-OH.
-
I135919-1g(R)-Boc-4-methyl-β-Phe-OH.
-
I135919-250mg(R)-Boc-4-methyl-β-Phe-OH.
-
I134924-1g(R)-Boc-β-Tyr-OH.
-
I134924-250mg(R)-Boc-β-Tyr-OH.
-
I134924-50mg(R)-Boc-β-Tyr-OH.
-
R343601-1mgButaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and animal tissues and
-
R343601-500μgButaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and animal tissues and
-
R355659-100mgA potential prodrug of carnitine, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+.
-
R355659-10mgA potential prodrug of carnitine, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+.
-
R355659-25mgA potential prodrug of carnitine, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+.